Log in to save to my catalogue

Comparing HCC arterial tumour vascularisation on baseline imaging and after lipiodol cTACE: how do e...

Comparing HCC arterial tumour vascularisation on baseline imaging and after lipiodol cTACE: how do e...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2359147574

Comparing HCC arterial tumour vascularisation on baseline imaging and after lipiodol cTACE: how do estimations of enhancing tumour volumes differ on contrast-enhanced MR and CT?

About this item

Full title

Comparing HCC arterial tumour vascularisation on baseline imaging and after lipiodol cTACE: how do estimations of enhancing tumour volumes differ on contrast-enhanced MR and CT?

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

European radiology, 2020-03, Vol.30 (3), p.1601-1608

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Objectives
In this study, pre-treatment target lesion vascularisation in either contrast-enhanced (CE) CT or MRI and post-treatment lipiodol deposition in native CT scans were compared in HCC patients who underwent their first cTACE treatment. We analysed the impact of stratification according to cTACE selectivity on these correlations.
Metho...

Alternative Titles

Full title

Comparing HCC arterial tumour vascularisation on baseline imaging and after lipiodol cTACE: how do estimations of enhancing tumour volumes differ on contrast-enhanced MR and CT?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2359147574

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2359147574

Other Identifiers

ISSN

0938-7994

E-ISSN

1432-1084

DOI

10.1007/s00330-019-06430-2

How to access this item